Product Images Venlafaxine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 53002-2365 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl530022365
Figure 1: Effect of interacting drugs on the pharmacokinetics of venlafaxine and active metabolite O-desmethylvenlafaxine (ODV). - venlafaxine fig1
This is a report on the PK Fold Change and 90% CI recommendation for interacting drug cimetane and analyte aniatxine, vov and venistaxing. The report recommends caution while using this drug combination in patients with hypertension, elderly patients, and those with hepatic dysfunction. The clinical significance of the reported changes is unknown, and therefore the use of these drugs should be closely monitored with no dose adjustment required.*
Figure 2: Effect of venlafaxine on the pharmacokinetics interacting drugs and their active metabolites. - venlafaxine fig2
Figure 3: Pharmacokinetics of venlafaxine and its metabolite O-desmethylvenlafaxine (ODV) in special populations. - venlafaxine fig3
Chemical Structure - venlafaxine str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.